The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vaccine Vial Market Research Report 2025
Synopsis
Vaccine bottles are made of special glass, usually containing 2 ml to 100 ml of liquid, with an average height of 45 mm.In addition, vaccine bottles must also be resistant to low temperatures and be able to withstand the wear and tear caused by global transportation.
The global Vaccine Vial market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vaccine Vial, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Vial.
Report Scope
The Vaccine Vial market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine Vial market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Vial manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Schott
Nippon Electric Glass
Corning
DWK Life Sciences
Richland Glass
Nipro
Pacific Vial Manufacturing
Origin Ltd
Stevanato Group
SGD Pharma
Piramal Glass
Zheng Chuan
Shandong Pharmaceutical Glass
Gerresheimer
Four Stars Glass
JOTOP Glass
Segment by Type
by Capacity
Single Dose
Multi-dose
by Product Type
Molded Glass Vial
Tubular Glass Vial
Segment by Application
Preventive Vaccine
Therapeutic Vaccine
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccine Vial manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccine Vial in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Vaccine bottles are made of special glass, usually containing 2 ml to 100 ml of liquid, with an average height of 45 mm.In addition, vaccine bottles must also be resistant to low temperatures and be able to withstand the wear and tear caused by global transportation.
The global Vaccine Vial market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vaccine Vial, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Vial.
Report Scope
The Vaccine Vial market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine Vial market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Vial manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Schott
Nippon Electric Glass
Corning
DWK Life Sciences
Richland Glass
Nipro
Pacific Vial Manufacturing
Origin Ltd
Stevanato Group
SGD Pharma
Piramal Glass
Zheng Chuan
Shandong Pharmaceutical Glass
Gerresheimer
Four Stars Glass
JOTOP Glass
Segment by Type
by Capacity
Single Dose
Multi-dose
by Product Type
Molded Glass Vial
Tubular Glass Vial
Segment by Application
Preventive Vaccine
Therapeutic Vaccine
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccine Vial manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccine Vial in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Vaccine Vial Market Overview
1.1 Product Overview and Scope of Vaccine Vial
1.2 Vaccine Vial Segment by Capacity
1.2.1 Global Vaccine Vial Market Value Comparison by Capacity (2024-2030)
1.2.2 Single Dose
1.2.3 Multi-dose
1.3 Vaccine Vial Segment by Application
1.3.1 Global Vaccine Vial Market Value by Application: (2024-2030)
1.3.2 Preventive Vaccine
1.3.3 Therapeutic Vaccine
1.4 Global Vaccine Vial Market Size Estimates and Forecasts
1.4.1 Global Vaccine Vial Revenue 2019-2030
1.4.2 Global Vaccine Vial Sales 2019-2030
1.4.3 Global Vaccine Vial Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vaccine Vial Market Competition by Manufacturers
2.1 Global Vaccine Vial Sales Market Share by Manufacturers (2019-2024)
2.2 Global Vaccine Vial Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Vaccine Vial Average Price by Manufacturers (2019-2024)
2.4 Global Vaccine Vial Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccine Vial, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccine Vial, Product Type & Application
2.7 Vaccine Vial Market Competitive Situation and Trends
2.7.1 Vaccine Vial Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vaccine Vial Players Market Share by Revenue
2.7.3 Global Vaccine Vial Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaccine Vial Retrospective Market Scenario by Region
3.1 Global Vaccine Vial Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vaccine Vial Global Vaccine Vial Sales by Region: 2019-2030
3.2.1 Global Vaccine Vial Sales by Region: 2019-2024
3.2.2 Global Vaccine Vial Sales by Region: 2025-2030
3.3 Global Vaccine Vial Global Vaccine Vial Revenue by Region: 2019-2030
3.3.1 Global Vaccine Vial Revenue by Region: 2019-2024
3.3.2 Global Vaccine Vial Revenue by Region: 2025-2030
3.4 North America Vaccine Vial Market Facts & Figures by Country
3.4.1 North America Vaccine Vial Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vaccine Vial Sales by Country (2019-2030)
3.4.3 North America Vaccine Vial Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vaccine Vial Market Facts & Figures by Country
3.5.1 Europe Vaccine Vial Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vaccine Vial Sales by Country (2019-2030)
3.5.3 Europe Vaccine Vial Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccine Vial Market Facts & Figures by Country
3.6.1 Asia Pacific Vaccine Vial Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vaccine Vial Sales by Country (2019-2030)
3.6.3 Asia Pacific Vaccine Vial Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vaccine Vial Market Facts & Figures by Country
3.7.1 Latin America Vaccine Vial Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vaccine Vial Sales by Country (2019-2030)
3.7.3 Latin America Vaccine Vial Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccine Vial Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccine Vial Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vaccine Vial Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vaccine Vial Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccine Vial Sales by Type (2019-2030)
4.1.1 Global Vaccine Vial Sales by Type (2019-2024)
4.1.2 Global Vaccine Vial Sales by Type (2025-2030)
4.1.3 Global Vaccine Vial Sales Market Share by Type (2019-2030)
4.2 Global Vaccine Vial Revenue by Type (2019-2030)
4.2.1 Global Vaccine Vial Revenue by Type (2019-2024)
4.2.2 Global Vaccine Vial Revenue by Type (2025-2030)
4.2.3 Global Vaccine Vial Revenue Market Share by Type (2019-2030)
4.3 Global Vaccine Vial Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vaccine Vial Sales by Application (2019-2030)
5.1.1 Global Vaccine Vial Sales by Application (2019-2024)
5.1.2 Global Vaccine Vial Sales by Application (2025-2030)
5.1.3 Global Vaccine Vial Sales Market Share by Application (2019-2030)
5.2 Global Vaccine Vial Revenue by Application (2019-2030)
5.2.1 Global Vaccine Vial Revenue by Application (2019-2024)
5.2.2 Global Vaccine Vial Revenue by Application (2025-2030)
5.2.3 Global Vaccine Vial Revenue Market Share by Application (2019-2030)
5.3 Global Vaccine Vial Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Schott
6.1.1 Schott Corporation Information
6.1.2 Schott Description and Business Overview
6.1.3 Schott Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Schott Vaccine Vial Product Portfolio
6.1.5 Schott Recent Developments/Updates
6.2 Nippon Electric Glass
6.2.1 Nippon Electric Glass Corporation Information
6.2.2 Nippon Electric Glass Description and Business Overview
6.2.3 Nippon Electric Glass Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Nippon Electric Glass Vaccine Vial Product Portfolio
6.2.5 Nippon Electric Glass Recent Developments/Updates
6.3 Corning
6.3.1 Corning Corporation Information
6.3.2 Corning Description and Business Overview
6.3.3 Corning Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Corning Vaccine Vial Product Portfolio
6.3.5 Corning Recent Developments/Updates
6.4 DWK Life Sciences
6.4.1 DWK Life Sciences Corporation Information
6.4.2 DWK Life Sciences Description and Business Overview
6.4.3 DWK Life Sciences Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
6.4.4 DWK Life Sciences Vaccine Vial Product Portfolio
6.4.5 DWK Life Sciences Recent Developments/Updates
6.5 Richland Glass
6.5.1 Richland Glass Corporation Information
6.5.2 Richland Glass Description and Business Overview
6.5.3 Richland Glass Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Richland Glass Vaccine Vial Product Portfolio
6.5.5 Richland Glass Recent Developments/Updates
6.6 Nipro
6.6.1 Nipro Corporation Information
6.6.2 Nipro Description and Business Overview
6.6.3 Nipro Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nipro Vaccine Vial Product Portfolio
6.6.5 Nipro Recent Developments/Updates
6.7 Pacific Vial Manufacturing
6.6.1 Pacific Vial Manufacturing Corporation Information
6.6.2 Pacific Vial Manufacturing Description and Business Overview
6.6.3 Pacific Vial Manufacturing Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pacific Vial Manufacturing Vaccine Vial Product Portfolio
6.7.5 Pacific Vial Manufacturing Recent Developments/Updates
6.8 Origin Ltd
6.8.1 Origin Ltd Corporation Information
6.8.2 Origin Ltd Description and Business Overview
6.8.3 Origin Ltd Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Origin Ltd Vaccine Vial Product Portfolio
6.8.5 Origin Ltd Recent Developments/Updates
6.9 Stevanato Group
6.9.1 Stevanato Group Corporation Information
6.9.2 Stevanato Group Description and Business Overview
6.9.3 Stevanato Group Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Stevanato Group Vaccine Vial Product Portfolio
6.9.5 Stevanato Group Recent Developments/Updates
6.10 SGD Pharma
6.10.1 SGD Pharma Corporation Information
6.10.2 SGD Pharma Description and Business Overview
6.10.3 SGD Pharma Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
6.10.4 SGD Pharma Vaccine Vial Product Portfolio
6.10.5 SGD Pharma Recent Developments/Updates
6.11 Piramal Glass
6.11.1 Piramal Glass Corporation Information
6.11.2 Piramal Glass Vaccine Vial Description and Business Overview
6.11.3 Piramal Glass Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Piramal Glass Vaccine Vial Product Portfolio
6.11.5 Piramal Glass Recent Developments/Updates
6.12 Zheng Chuan
6.12.1 Zheng Chuan Corporation Information
6.12.2 Zheng Chuan Vaccine Vial Description and Business Overview
6.12.3 Zheng Chuan Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zheng Chuan Vaccine Vial Product Portfolio
6.12.5 Zheng Chuan Recent Developments/Updates
6.13 Shandong Pharmaceutical Glass
6.13.1 Shandong Pharmaceutical Glass Corporation Information
6.13.2 Shandong Pharmaceutical Glass Vaccine Vial Description and Business Overview
6.13.3 Shandong Pharmaceutical Glass Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Shandong Pharmaceutical Glass Vaccine Vial Product Portfolio
6.13.5 Shandong Pharmaceutical Glass Recent Developments/Updates
6.14 Gerresheimer
6.14.1 Gerresheimer Corporation Information
6.14.2 Gerresheimer Vaccine Vial Description and Business Overview
6.14.3 Gerresheimer Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Gerresheimer Vaccine Vial Product Portfolio
6.14.5 Gerresheimer Recent Developments/Updates
6.15 Four Stars Glass
6.15.1 Four Stars Glass Corporation Information
6.15.2 Four Stars Glass Vaccine Vial Description and Business Overview
6.15.3 Four Stars Glass Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Four Stars Glass Vaccine Vial Product Portfolio
6.15.5 Four Stars Glass Recent Developments/Updates
6.16 JOTOP Glass
6.16.1 JOTOP Glass Corporation Information
6.16.2 JOTOP Glass Vaccine Vial Description and Business Overview
6.16.3 JOTOP Glass Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
6.16.4 JOTOP Glass Vaccine Vial Product Portfolio
6.16.5 JOTOP Glass Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccine Vial Industry Chain Analysis
7.2 Vaccine Vial Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccine Vial Production Mode & Process
7.4 Vaccine Vial Sales and Marketing
7.4.1 Vaccine Vial Sales Channels
7.4.2 Vaccine Vial Distributors
7.5 Vaccine Vial Customers
8 Vaccine Vial Market Dynamics
8.1 Vaccine Vial Industry Trends
8.2 Vaccine Vial Market Drivers
8.3 Vaccine Vial Market Challenges
8.4 Vaccine Vial Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Vaccine Vial Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Vaccine Vial Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Vaccine Vial Market Competitive Situation by Manufacturers in 2023
Table 4. Global Vaccine Vial Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Vaccine Vial Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Vaccine Vial Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Vaccine Vial Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Vaccine Vial Average Price (US$/K Units) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Vaccine Vial, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vaccine Vial, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vaccine Vial, Product Type & Application
Table 12. Global Key Manufacturers of Vaccine Vial, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vaccine Vial by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Vial as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vaccine Vial Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Vaccine Vial Sales by Region (2019-2024) & (K Units)
Table 18. Global Vaccine Vial Sales Market Share by Region (2019-2024)
Table 19. Global Vaccine Vial Sales by Region (2025-2030) & (K Units)
Table 20. Global Vaccine Vial Sales Market Share by Region (2025-2030)
Table 21. Global Vaccine Vial Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Vaccine Vial Revenue Market Share by Region (2019-2024)
Table 23. Global Vaccine Vial Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Vaccine Vial Revenue Market Share by Region (2025-2030)
Table 25. North America Vaccine Vial Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Vaccine Vial Sales by Country (2019-2024) & (K Units)
Table 27. North America Vaccine Vial Sales by Country (2025-2030) & (K Units)
Table 28. North America Vaccine Vial Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Vaccine Vial Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Vaccine Vial Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Vaccine Vial Sales by Country (2019-2024) & (K Units)
Table 32. Europe Vaccine Vial Sales by Country (2025-2030) & (K Units)
Table 33. Europe Vaccine Vial Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Vaccine Vial Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Vaccine Vial Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Vaccine Vial Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Vaccine Vial Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Vaccine Vial Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Vaccine Vial Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Vaccine Vial Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Vaccine Vial Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Vaccine Vial Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Vaccine Vial Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Vaccine Vial Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Vaccine Vial Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Vaccine Vial Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Vaccine Vial Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Vaccine Vial Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Vaccine Vial Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Vaccine Vial Sales (K Units) by Type (2019-2024)
Table 51. Global Vaccine Vial Sales (K Units) by Type (2025-2030)
Table 52. Global Vaccine Vial Sales Market Share by Type (2019-2024)
Table 53. Global Vaccine Vial Sales Market Share by Type (2025-2030)
Table 54. Global Vaccine Vial Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Vaccine Vial Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Vaccine Vial Revenue Market Share by Type (2019-2024)
Table 57. Global Vaccine Vial Revenue Market Share by Type (2025-2030)
Table 58. Global Vaccine Vial Price (US$/K Units) by Type (2019-2024)
Table 59. Global Vaccine Vial Price (US$/K Units) by Type (2025-2030)
Table 60. Global Vaccine Vial Sales (K Units) by Application (2019-2024)
Table 61. Global Vaccine Vial Sales (K Units) by Application (2025-2030)
Table 62. Global Vaccine Vial Sales Market Share by Application (2019-2024)
Table 63. Global Vaccine Vial Sales Market Share by Application (2025-2030)
Table 64. Global Vaccine Vial Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Vaccine Vial Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Vaccine Vial Revenue Market Share by Application (2019-2024)
Table 67. Global Vaccine Vial Revenue Market Share by Application (2025-2030)
Table 68. Global Vaccine Vial Price (US$/K Units) by Application (2019-2024)
Table 69. Global Vaccine Vial Price (US$/K Units) by Application (2025-2030)
Table 70. Schott Corporation Information
Table 71. Schott Description and Business Overview
Table 72. Schott Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 73. Schott Vaccine Vial Product
Table 74. Schott Recent Developments/Updates
Table 75. Nippon Electric Glass Corporation Information
Table 76. Nippon Electric Glass Description and Business Overview
Table 77. Nippon Electric Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 78. Nippon Electric Glass Vaccine Vial Product
Table 79. Nippon Electric Glass Recent Developments/Updates
Table 80. Corning Corporation Information
Table 81. Corning Description and Business Overview
Table 82. Corning Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 83. Corning Vaccine Vial Product
Table 84. Corning Recent Developments/Updates
Table 85. DWK Life Sciences Corporation Information
Table 86. DWK Life Sciences Description and Business Overview
Table 87. DWK Life Sciences Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 88. DWK Life Sciences Vaccine Vial Product
Table 89. DWK Life Sciences Recent Developments/Updates
Table 90. Richland Glass Corporation Information
Table 91. Richland Glass Description and Business Overview
Table 92. Richland Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 93. Richland Glass Vaccine Vial Product
Table 94. Richland Glass Recent Developments/Updates
Table 95. Nipro Corporation Information
Table 96. Nipro Description and Business Overview
Table 97. Nipro Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 98. Nipro Vaccine Vial Product
Table 99. Nipro Recent Developments/Updates
Table 100. Pacific Vial Manufacturing Corporation Information
Table 101. Pacific Vial Manufacturing Description and Business Overview
Table 102. Pacific Vial Manufacturing Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 103. Pacific Vial Manufacturing Vaccine Vial Product
Table 104. Pacific Vial Manufacturing Recent Developments/Updates
Table 105. Origin Ltd Corporation Information
Table 106. Origin Ltd Description and Business Overview
Table 107. Origin Ltd Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 108. Origin Ltd Vaccine Vial Product
Table 109. Origin Ltd Recent Developments/Updates
Table 110. Stevanato Group Corporation Information
Table 111. Stevanato Group Description and Business Overview
Table 112. Stevanato Group Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 113. Stevanato Group Vaccine Vial Product
Table 114. Stevanato Group Recent Developments/Updates
Table 115. SGD Pharma Corporation Information
Table 116. SGD Pharma Description and Business Overview
Table 117. SGD Pharma Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 118. SGD Pharma Vaccine Vial Product
Table 119. SGD Pharma Recent Developments/Updates
Table 120. Piramal Glass Corporation Information
Table 121. Piramal Glass Description and Business Overview
Table 122. Piramal Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 123. Piramal Glass Vaccine Vial Product
Table 124. Piramal Glass Recent Developments/Updates
Table 125. Zheng Chuan Corporation Information
Table 126. Zheng Chuan Description and Business Overview
Table 127. Zheng Chuan Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 128. Zheng Chuan Vaccine Vial Product
Table 129. Zheng Chuan Recent Developments/Updates
Table 130. Shandong Pharmaceutical Glass Corporation Information
Table 131. Shandong Pharmaceutical Glass Description and Business Overview
Table 132. Shandong Pharmaceutical Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 133. Shandong Pharmaceutical Glass Vaccine Vial Product
Table 134. Shandong Pharmaceutical Glass Recent Developments/Updates
Table 135. Gerresheimer Corporation Information
Table 136. Gerresheimer Description and Business Overview
Table 137. Gerresheimer Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 138. Gerresheimer Vaccine Vial Product
Table 139. Gerresheimer Recent Developments/Updates
Table 140. Four Stars Glass Corporation Information
Table 141. Four Stars Glass Description and Business Overview
Table 142. Four Stars Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 143. Four Stars Glass Vaccine Vial Product
Table 144. Four Stars Glass Recent Developments/Updates
Table 145. JOTOP Glass Corporation Information
Table 146. JOTOP Glass Description and Business Overview
Table 147. JOTOP Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
Table 148. JOTOP Glass Vaccine Vial Product
Table 149. JOTOP Glass Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Vaccine Vial Distributors List
Table 153. Vaccine Vial Customers List
Table 154. Vaccine Vial Market Trends
Table 155. Vaccine Vial Market Drivers
Table 156. Vaccine Vial Market Challenges
Table 157. Vaccine Vial Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vaccine Vial
Figure 2. Global Vaccine Vial Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Vaccine Vial Market Share by Type in 2023 & 2030
Figure 4. Single Dose Product Picture
Figure 5. Multi-dose Product Picture
Figure 6. Global Vaccine Vial Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Vaccine Vial Market Share by Application in 2023 & 2030
Figure 8. Preventive Vaccine
Figure 9. Therapeutic Vaccine
Figure 10. Global Vaccine Vial Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Vaccine Vial Market Size (2019-2030) & (US$ Million)
Figure 12. Global Vaccine Vial Sales (2019-2030) & (K Units)
Figure 13. Global Vaccine Vial Average Price (US$/K Units) & (2019-2030)
Figure 14. Vaccine Vial Report Years Considered
Figure 15. Vaccine Vial Sales Share by Manufacturers in 2023
Figure 16. Global Vaccine Vial Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Vaccine Vial Players: Market Share by Revenue in 2023
Figure 18. Vaccine Vial Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Vaccine Vial Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Vaccine Vial Sales Market Share by Country (2019-2030)
Figure 21. North America Vaccine Vial Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Vaccine Vial Sales Market Share by Country (2019-2030)
Figure 25. Europe Vaccine Vial Revenue Market Share by Country (2019-2030)
Figure 26. Germany Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Vaccine Vial Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Vaccine Vial Revenue Market Share by Region (2019-2030)
Figure 33. China Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Vaccine Vial Sales Market Share by Country (2019-2030)
Figure 44. Latin America Vaccine Vial Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Vaccine Vial Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Vaccine Vial Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Vaccine Vial Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Vaccine Vial by Type (2019-2030)
Figure 54. Global Revenue Market Share of Vaccine Vial by Type (2019-2030)
Figure 55. Global Vaccine Vial Price (US$/K Units) by Type (2019-2030)
Figure 56. Global Sales Market Share of Vaccine Vial by Application (2019-2030)
Figure 57. Global Revenue Market Share of Vaccine Vial by Application (2019-2030)
Figure 58. Global Vaccine Vial Price (US$/K Units) by Application (2019-2030)
Figure 59. Vaccine Vial Value Chain
Figure 60. Vaccine Vial Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
